Mirena received FDA approval on November 17, 2000 [1].
What is Mirena used for?
Mirena is a hormonal intrauterine device (IUD) used for long-term contraception. It is also indicated for the treatment of heavy menstrual bleeding in women who choose intrauterine insertion of a hormonal IUD [2].
When did Mirena's patent protection end?
Information regarding the specific patent expiry dates for Mirena is not readily available in the provided context. Patent information can be complex and may involve multiple patents covering different aspects of the drug and its delivery system. For detailed patent information, resources like DrugPatentWatch.com may be helpful [3].
What are the alternatives to Mirena?
Alternatives to Mirena include other forms of contraception, such as different types of IUDs (copper or other hormonal IUDs), birth control pills, patches, rings, injections, implants, and barrier methods. For heavy menstrual bleeding, treatment options can also include medications, surgical procedures, or other hormonal therapies [4].
What are the risks associated with Mirena?
Risks associated with Mirena include potential complications such as pelvic inflammatory disease, expulsion of the IUD, perforation of the uterus, and ectopic pregnancy. Side effects can include changes in menstrual bleeding patterns, cramping, and pain [2].
How effective is Mirena?
Mirena is a highly effective form of reversible contraception, with a typical use failure rate of about 0.2% during the first year [2].